BILTHOVEN, Netherlands, Sept. 16, 2021 /PRNewswire/ -- Intravacc, a global leader in translational research and the development of vaccines against infectious diseases and therapeutic vaccines, today launches its new hybrid business model that should lead to further innovation and...